Russian food company, EFKO, has entered into an agreement to establish a $500 million production site for the sweet protein brazzein in the UAE. This project, set to be the world's largest biotechnology cluster, aims to offer a healthier sugar substitute to the Middle East, a region grappling with high rates of obesity and diabetes. The project, which includes the construction of three production lines, is slated to be fully operational by 2023.